This is also relevant in lung cancer where DAB2 expression has been suggested as a marker for epithelioid mesothelioma which has 80–98% DAB2 positivity compared to 3–23% for pulmonary adenocarcinoma cases [27,28]. The gene discussed is DAB2; the disease is lung carcinoma.